Skip to search boxSkip to navigationSkip to main content

Antipsychotic Polypharmacy and Metabolic Disorder Risk in Individuals With Schizophrenia

*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Journal (Volume, Issue Number)

Psychiatric Times (Volume 40, Issue 12)

Publication milestones

  • Published - 12/2023

Publication status

Published - 12/2023

ISSN

0893-2905

Publication IDs

  • Scopus: 85194459110

Publication metrics

Metrics

Fractional count
1
Fractional count
1
Fractional count
1
Fractional count
1

Funding Details

The author reports that he receives research support from Augusta University, the National Institute of Mental Health, and the Stanley Medical Research Institute.
FundersFunding numbersAugusta University-
NIMH
-
SMRI
-